_version_ 1783591734158032896
author Schmid-Grendelmeier, Peter
Steiger, Peter
Naegeli, Mirjam C.
Kolm, Isabel
Lang, Claudia Cécile Valérie
Maverakis, Emanual
Brüggen, Marie-Charlotte
author_facet Schmid-Grendelmeier, Peter
Steiger, Peter
Naegeli, Mirjam C.
Kolm, Isabel
Lang, Claudia Cécile Valérie
Maverakis, Emanual
Brüggen, Marie-Charlotte
author_sort Schmid-Grendelmeier, Peter
collection PubMed
description
format Online
Article
Text
id pubmed-7543785
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher American Academy of Allergy, Asthma & Immunology
record_format MEDLINE/PubMed
spelling pubmed-75437852020-10-09 Benralizumab for severe DRESS in two COVID-19 patients Schmid-Grendelmeier, Peter Steiger, Peter Naegeli, Mirjam C. Kolm, Isabel Lang, Claudia Cécile Valérie Maverakis, Emanual Brüggen, Marie-Charlotte J Allergy Clin Immunol Pract Clinical Communications American Academy of Allergy, Asthma & Immunology 2021-01 2020-10-08 /pmc/articles/PMC7543785/ /pubmed/33039646 http://dx.doi.org/10.1016/j.jaip.2020.09.039 Text en © 2020 American Academy of Allergy, Asthma & Immunology. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Clinical Communications
Schmid-Grendelmeier, Peter
Steiger, Peter
Naegeli, Mirjam C.
Kolm, Isabel
Lang, Claudia Cécile Valérie
Maverakis, Emanual
Brüggen, Marie-Charlotte
Benralizumab for severe DRESS in two COVID-19 patients
title Benralizumab for severe DRESS in two COVID-19 patients
title_full Benralizumab for severe DRESS in two COVID-19 patients
title_fullStr Benralizumab for severe DRESS in two COVID-19 patients
title_full_unstemmed Benralizumab for severe DRESS in two COVID-19 patients
title_short Benralizumab for severe DRESS in two COVID-19 patients
title_sort benralizumab for severe dress in two covid-19 patients
topic Clinical Communications
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543785/
https://www.ncbi.nlm.nih.gov/pubmed/33039646
http://dx.doi.org/10.1016/j.jaip.2020.09.039
work_keys_str_mv AT schmidgrendelmeierpeter benralizumabforseveredressintwocovid19patients
AT steigerpeter benralizumabforseveredressintwocovid19patients
AT naegelimirjamc benralizumabforseveredressintwocovid19patients
AT kolmisabel benralizumabforseveredressintwocovid19patients
AT langclaudiacecilevalerie benralizumabforseveredressintwocovid19patients
AT maverakisemanual benralizumabforseveredressintwocovid19patients
AT bruggenmariecharlotte benralizumabforseveredressintwocovid19patients